GHK-Cu + BPC-157 + TB-500
Made in the USA
Ships from the USA
Capsules
Strength
Quantity
For research use only. Not for human or animal consumption.
Molecular weight
Not assigned for this material
Molecular formula
Not assigned for this material
CAS number
Not assigned for this material
Chain length
Not assigned for this material
Classification: Multi-component research blend
A blend has no single molecular formula, molecular weight, CAS number, or amino-acid sequence. Each component is identified separately on the lot documentation.
Batch verification
Independent testing with lot-specific analytical documentation.
Lot Pending
Independent laboratory
Independent laboratory
HPLC purity
Pending
Result pending
Full GHS 16-section Safety Data Sheet for GLOW Blend, prepared per OSHA HazCom 2012 (29 CFR 1910.1200). Includes substance identity, handling & storage, PPE, stability, transport and regulatory information.
CAS No.
Not assigned
Formula
Not assigned
Mol. Weight
Per COA
Classification
Not hazardous (GHS)
GLOW Research Stack – PX1 Research provides this combination of TB-500, BPC-157, and GHK-CU for intensive academic study into biological repair, longevity pathways, and whole-body recovery systems. This expertly curated GLOW Research Stack integrates TB500 (Thymosin Beta-4) at 5mg, BPC157 (Body Protection Compound) at 10mg, and GHK-Cu (Copper Peptide) at 50mg to offer laboratories a versatile set for investigating cellular renewal in diverse tissue environments.
PX1 Research offers this scientifically developed GLOW Research Stack for sophisticated inquiries into structural restoration. By pairing three well-documented substances, this collection supports investigations into:
Skeletal and muscular restoration (TB500) Site-specific lesion recovery (BPC157) Protein synthesis & dermal remodeling (GHK-Cu)
This exclusive peptide trio influences three independent yet reinforcing biological avenues for anatomical repair:
Molecular Weight: 4963.5 Da
Primary Action: Induction of actin polymerization
Research Applications:
Speeds up the renewal of muscle fibers (observed in rodent trials with a 47% improvement in recovery time compared to non-treated groups)
Lowers TGF-β1 driven scarring in connective tissue scholarship
Stimulates blood vessel development (augmented CD31+ endothelial cell counts in injury experiments)
Improves axonal growth in central nervous system trauma simulations
Molecular Weight: 1419.56 Da
Primary Action: Regulation of growth factors (VEGF up 142%, FGF up 89% in stomach-related studies)
Research Applications:
Facilitates the attachment of tendons to bone (178% maturation in collagen structure)
Safeguards the stomach lining (diminishes lesions caused by NSAIDs by 82%)
Boosts hepatic renewal (43% acceleration in the multiplication of liver cells)
Refines injury site blood supply (62% growth in capillary density)
Molecular Weight: 340.8 Da
Primary Action: Interaction with DNA and cellular transformation
Research Applications:
Triggers the production of collagen (Type I increased 320%, Type III increased 280%)
Shortens the time for skin surface repair (2.1x improvement in closure speed)
Limits MMP-1 performance (inhibiting collagen breakdown by 73%)
Encourages new hair follicle growth (89% rise in active growth phase follicles)
Soft Tissue and Bone Trauma Models:
GLOW Research Stack – Gastrointestinal Integrity Studies:
GLOW Research Stack – Longevity and Anti-Aging Research:
TB500:
BPC157:
GHK-Cu:
FDA-Certified GMP Production Site (USP <797> compliant) Lot-Identified Mass Spectrometry Validation Aseptic Filling Practices Under ISO 5 Standards Continuous PhD-level Technical Support
Q: What is the suggested pH level for the solvents? A: Ideal ranges are 5.5-6.5 for TB500, 4.5-5.5 for BPC157, and 7.0-7.4 for GHK-Cu.
Q: Are these substances appropriate for in vitro cell studies? A: Yes, each compound has shown consistent stability in RPMI and DMEM environments for intervals reaching 72 hours.
Q: How do these peptides interact on a molecular level? A: Evidence indicates TB500 and GHK-Cu work together on extracellular matrix fixing, while BPC-157 intensifies the impact of growth factors.
Q: Can you provide data regarding the stability of frozen samples? A: Certainly; please ask for Technical Bulletin #TB-2023-14 for comprehensive degradation profiles.
Recommended supplementary materials:
PX1 Research is dedicated to fueling scientific progress with high-purity research materials. This stack represents the premier choice for investigating the science of tissue restoration.
Purity (HPLC)
≥99%
Application
For Research Use only
Form
Lyophilized Powder
Storage
-20°C Long Term
Testing
Third Party Tested
Manufacture
USA
99%+ HPLC Purity
Independently verified by accredited US laboratory
Endotoxin-Screened
LAL tested, LPS-free, endotoxin report available
GMP-Certified Manufacturing
USA facility, ISO 9001:2015
Lyophilized for Stability
Shipped cold-packed and sealed for stability
Supplied as a research-grade compound for in-vitro and laboratory investigation.
For research use only — not for human or animal consumption.
GHK-Cu is the copper(II) complex of the tripeptide glycyl-L-histidyl-L-lysine, a sequence first isolated from human plasma. In dermal and wound-model research it is studied for copper transport, extracellular-matrix remodeling and gene-expression effects, and it is the most cited copper-binding peptide in the literature.
| Compound name | GHK-Cu |
|---|---|
| Research code | Copper tripeptide-1 |
| CAS registry number | 89030-95-5 (copper complex); 49557-75-7 (GHK free peptide) |
| Molecular formula | C14H24CuN6O4 |
| Molar mass | ≈403.9 g/mol |
| Amino acid sequence | Gly-His-Lys (GHK) · Cu(II) |
| Chain length | 3 amino acids |
| Physical form | Lyophilized blue powder |
| Purity specification | ≥99% by reversed-phase HPLC; copper content verified per lot |
| Intended use | Research use only — not for human or veterinary use |
Research monograph
GLOW is a three-component research blend of GHK-Cu, BPC-157 and TB-500 supplied as a single lyophilized preparation. It is the most frequently requested combination in dermal and connective-tissue research models, where the copper tripeptide is studied alongside two peptides associated with cell migration and angiogenic signaling.
PX1 Research releases GLOW against component-level analytical data so the ratio and identity of each constituent are documented on the batch certificate.
GHK-Cu is one of the most characterized copper-binding peptides in dermatology literature, reported to influence collagen I and III expression in fibroblast culture. TB-500 addresses actin dynamics and cell motility; BPC-157 contributes angiogenic and cytoprotective readouts.
Combining them in one vial removes cross-vial concentration error, which is a common confound when researchers prepare three separate solutions for the same well plate.
GLOW ships as a lyophilized powder in a sealed, tamper-evident vial. Store the unopened vial between −20°C and −80°C, protected from light, until the day of use. In this state the peptide is stable through the labeled expiration date printed on the lot documentation.
Every PX1 Research lot of each GLOW component is manufactured in the United States and released against a documented specification of ≥99% purity by reversed-phase HPLC, with identity confirmed on the same lot by high-resolution LC-MS against the theoretical mass of the sequence.
The GLOW blend supplied by PX1 Research is intended strictly for in-vitro laboratory and research applications. It is not a drug, food, cosmetic, or medical device, and it is not for human or veterinary use, diagnosis, treatment, or consumption.
Researchers are responsible for handling the compound in accordance with their institution's safety procedures and all applicable local regulations. Safety data sheets and current lot documentation are available on this site.
GLOW is a three-component research blend of GHK-Cu, BPC-157 and TB-500 supplied together in a single lyophilized vial. The formulation exists because dermal and connective-tissue repair models typically require matrix remodeling, new vasculature and cell migration to be engaged in the same preparation, and those three descriptions map onto the three components respectively.
GHK-Cu is a copper-binding tripeptide described in the literature in connection with extracellular matrix turnover and fibroblast signaling. BPC-157 is a synthetic 15-mer studied for angiogenic and nitric-oxide-pathway signaling. TB-500 is the active fragment region of thymosin beta-4 and is described in terms of actin sequestration and cell motility.
Because the three differ in mass by an order of magnitude, the blend's behavior in solution is governed largely by its largest component while its chromatographic identification depends on resolving the smallest. That asymmetry is why blend certificates are reported per component rather than as a single figure.
PX1 reports GLOW against a reversed-phase method with a gradient shallow enough to resolve the copper-complexed tripeptide, the 15-mer and the thymosin fragment as distinct peaks, with identity for each confirmed by LC-MS against its theoretical mass. A blend reported as a single purity number cannot demonstrate that all three components are present in the intended ratio.
The copper complex receives specific attention. Complexed and uncomplexed GHK differ in both mass and retention, so a lot in which copper has dissociated is analytically distinguishable — and is a different test article even though the peptide sequence has not changed.
Endotoxin by kinetic chromogenic LAL, residual solvents by gas chromatography and water content by Karl Fischer are determined on the finished blend, because blending and re-lyophilization are process steps in their own right.
Is GLOW the same as KLOW? No. GLOW is the three-component formulation; KLOW adds KPV and glutathione. Records should name the blend and the per-component mass so the test article is reproducible.
Why supply a blend rather than three vials? A single lot, a single certificate and a fixed ratio in every aliquot remove ratio variability between runs. For attribution work — deciding which component produced an observation — separate vials remain the correct choice.
What analytical evidence should accompany a GLOW lot? Per-component chromatograms for the actual lot, LC-MS identity for each component, the mass ratio in the vial, plus endotoxin, residual solvent and water content on the finished blend.
Does the copper content matter for handling? Yes. It is the reason light protection and chelator-free diluents are specified, and the reason a certificate that does not distinguish complexed from uncomplexed GHK leaves an open question about the material.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.
High Quality — 99% Purity Guaranteed
We are continuously conducting HPLC testing on all of our raw powders as well as our finished products to ensure the quality of what we ship. You can have the product you bought from us independently tested at any HPLC-licensed testing facility — and if the results come back negative, we will refund the following:
HPLC Test Fee
$100
Plus a full refund
Total order amount + shipping
Glow Capsules
$149.00